REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activityJennifer S. Carew, Steffan T. Nawrocki, Madison E. Gamble et al.|Cancer Letters|2025Cited by 8
Targeting autophagy: A promising approach for the treatment of breast cancer brain metastasesSteffan T. Nawrocki, Jennifer S. Carew, Claudia M. Espitia et al.|Clinical and Translational Discovery|2024Cited by 1